Ozturk Mert Burak, Li Yinghui, Tergaonkar Vinay
Division of Cancer Genetics and Therapeutics, Laboratory of NFκB Signaling, Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore 138673, Singapore.
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore 117597, Singapore.
Antioxidants (Basel). 2017 Feb 28;6(1):17. doi: 10.3390/antiox6010017.
The telomerase ribonucleoprotein complex has a pivotal role in regulating the proliferation and senescence of normal somatic cells as well as cancer cells. This complex is comprised mainly of telomerase reverse transcriptase (TERT), telomerase RNA component (TERC) and other associated proteins that function to elongate telomeres localized at the end of the chromosomes. While reactivation of telomerase is a major hallmark of most cancers, together with the synergistic activation of other oncogenic signals, deficiency in telomerase and telomeric proteins might lead to aging and senescence-associated disorders. Therefore, it is critically important to understand the canonical as well as non-canonical functions of telomerase through TERT to develop a therapeutic strategy against telomerase-related diseases. In this review, we shed light on the regulation and function of telomerase, and current therapeutic strategies against telomerase in cancer and age-related diseases.
端粒酶核糖核蛋白复合体在调节正常体细胞和癌细胞的增殖与衰老中起关键作用。该复合体主要由端粒酶逆转录酶(TERT)、端粒酶RNA组分(TERC)以及其他相关蛋白组成,这些蛋白的功能是延长位于染色体末端的端粒。虽然端粒酶的重新激活是大多数癌症的一个主要标志,与其他致癌信号的协同激活一起,但端粒酶和端粒蛋白的缺陷可能导致衰老和与衰老相关的疾病。因此,通过TERT了解端粒酶的经典和非经典功能对于制定针对端粒酶相关疾病的治疗策略至关重要。在这篇综述中,我们阐述了端粒酶的调节和功能,以及目前针对癌症和与年龄相关疾病中端粒酶的治疗策略。